サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1427004

インスリンペンの世界市場

Global Insulin Pen Market
出版日: | 発行: BCC Research | ページ情報: 英文 78 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
インスリンペンの世界市場
出版日: 2024年02月15日
発行: BCC Research
ページ情報: 英文 78 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のインスリンペンの市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

  • 市場の見通し
  • 市場サマリー
  • レポートハイライト

第3章 市場概要・定義

  • 概要
  • 糖尿病
  • 1型糖尿病
  • 2型糖尿病
  • インスリンの役割
  • 糖尿病の治療
  • 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第4章 市場内訳：地域別

  • 市場概要・ディスカッション
  • 市場規模・予測
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第5章 市場内訳：発現時間別

  • 市場概要・ディスカッション
  • 持効性インスリン
  • 速効型インスリン
  • 中間型インスリン
  • 短時間作用型インスリン
  • 市場規模・予測
  • 持続型インスリンペン
  • 中間型インスリンペン
  • 短時間作用型インスリンペン
  • 速効型インスリンペン

第6章 市場内訳：エンドユーザー別

  • 市場概要
  • 病院
  • 薬局
  • 市場規模・予測
  • 世界のインスリンペンエンドユーザー別市場
  • 北米のエンドユーザー別市場
  • 欧州のエンドユーザー別市場
  • アジア太平洋のエンドユーザー別市場
  • その他の地域のエンドユーザー別市場

第7章 ESGの展開

  • 環境
  • 社交
  • ガバナンス
  • ケーススタディ
  • Novo Nordisk A/S
  • BCCによる総論

第8章 競合情勢

  • 概要と業界シナリオ
  • 企業シェア
  • 最近の主な展開

第9章 企業プロファイル

  • ASTRAZENECA
  • BIOCON
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • ELI LILLY AND CO.
  • JOHNSON & JOHNSON SERVICES INC.
  • MERCK & CO. INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI
  • VIATRIS INC.

第10章 付録：頭字語

図表

List of Tables

  • Summary Table : Global Market for Insulin Pens, by Type, Through 2028
  • Table 1 : Global Insulin Pens Market Drivers
  • Table 2 : Global Insulin Pens Market Restraints
  • Table 3 : Global Insulin Pens Market Challenges
  • Table 4 : Global Market for Insulin Pens, by Region, Through 2028
  • Table 5 : North American Market for Insulin Pens, by Type, Through 2028
  • Table 6 : European Market for Insulin Pens, by Type, Through 2028
  • Table 7 : Asia-Pacific Market for Insulin Pens, by Type, Through 2028
  • Table 8 : Rest of the World Market for Insulin Pens, by Type, Through 2028
  • Table 9 : Insulin Type and Features
  • Table 10 : Leading Insulin Products and Their Types
  • Table 11 : Global Market for Insulin Pens, by Onset Time, Through 2028
  • Table 12 : Global Market for Long-Acting Insulin Pens, by Region, Through 2028
  • Table 13 : Global Market for Intermediate-Acting Insulin Pens, by Region, Through 2028
  • Table 14 : Global Market for Short- Acting Insulin Pens, by Region, Through 2028
  • Table 15 : Global Market for Rapid-Acting Insulin Pens, by Region, Through 2028
  • Table 16 : Global Market for Insulin Pens for Hospitals, by Region, Through 2028
  • Table 17 : Global Market for Insulin Pens for Pharmacies, by Region, Through 2028
  • Table 18 : North American Market for Insulin Pens, by End User, Through 2028
  • Table 19 : European Market for Insulin Pens, by End User, Through 2028
  • Table 20 : Asia-Pacific Market for Insulin Pens, by End User, Through 2028
  • Table 21 : Rest of the World Market for Insulin Pens, by End User, Through 2028
  • Table 22 : Top Pharma Companies' ESG Risk Ratings
  • Table 23 : Novo Nordisk A/S: Key Environmental Performance Indicators, 2020-2022
  • Table 24 : Novo Nordisk A/S: Key Social Performance Indicators, 2020-2022
  • Table 25 : Novo Nordisk A/S: Key Governance Performance Indicators, 2020-2022
  • Table 26 : Global Market Share of Insulin Pens, by Company, 2022
  • Table 27 : Global Market Shares of Insulin Pens, by Product, 2022
  • Table 28 : Global Insulin Market, Product Sales Revenue, 2020-2022
  • Table 29 : Global Diabetes Treatment Market, Selected Recent Key Developments, September 2019-August 2022
  • Table 30 : AstraZeneca: Company Snapshot
  • Table 31 : AstraZeneca: Diabetology Product Information
  • Table 32 : AstraZeneca: Revenue, 2020-2022
  • Table 33 : AstraZeneca: Recent Key Developments, 2021-2023
  • Table 34 : Biocon: Company Snapshot
  • Table 35 : Biocon: Diabetology Product Information
  • Table 36 : Biocon: Revenue, 2020-2022
  • Table 37 : Biocon: Key Developments, 2021-2023
  • Table 38 : Boehringer Ingelheim International GmbH: Company Snapshot
  • Table 39 : Boehringer Ingelheim International GmbH: Diabetology Product Information
  • Table 40 : Boehringer Ingelheim International GmbH: Annual Revenue, 2020-2022
  • Table 41 : Boehringer Ingelheim International GmbH: Key Developments, 2019-2021
  • Table 42 : Eli Lilly and Co.: Company Snapshot
  • Table 43 : Eli Lilly and Co: Diabetology Product Information
  • Table 44 : Eli Lilly and Co: Annual Revenue, 2020-2022
  • Table 45 : Eli Lilly and Co: Recent Key Developments, 2020-2022
  • Table 46 : Johnson & Johnson Services Inc.: Company Snapshot
  • Table 47 : Johnson & Johnson Services Inc.: Diabetology Product Information
  • Table 48 : Johnson & Johnson Services Inc.: Annual Revenue, 2020-2022
  • Table 49 : Merck & Co. Inc.: Company Snapshot
  • Table 50 : Merck & Co. Inc.: Diabetology Product Information
  • Table 51 : Merck & Co. Inc.: Financials, 2020-2022
  • Table 52 : Merck & Co. Inc.: Key Developments, 2021
  • Table 53 : Novartis AG: Company Snapshot
  • Table 54 : Novartis AG: Diabetology Product Information
  • Table 55 : Novartis AG: Financials, 2020-2022
  • Table 56 : Novartis AG: Key Developments, 2023
  • Table 57 : Novo Nordisk A/S: Company Snapshot
  • Table 58 : Novo Nordisk A/S: Diabetology Product Information
  • Table 59 : Novo Nordisk A/S: Revenue, 2020-2022
  • Table 60 : Novo Nordisk A/S: Recent Developments, 2019-2022
  • Table 61 : Sanofi: Company Snapshot
  • Table 62 : Sanofi: Business Segment
  • Table 63 : Sanofi: Diabetology Product Information
  • Table 64 : Sanofi: Annual Revenue, 2020-2022
  • Table 65 : Sanofi: Key Developments, 2021-2023
  • Table 66 : Viatris Inc.: Company Snapshot
  • Table 67 : Viatris Inc.: Annual Revenue, 2020-2022
  • Table 68 : Viatris Inc.: Diabetology Product Information
  • Table 69 : Major Acronyms Used in This Report

List of Figures

  • Summary Figure A : Global Market for Insulin Pens, by Type, 2020-2028
  • Summary Figure B : Global Market Shares of Insulin Pens, by Type, 2022
  • Figure 1 : Market Dynamics for the Global Insulin Pens Market
  • Figure 2 : Global Market Shares of Insulin Pens, by Region, 2022
  • Figure 3 : North American Market Shares of Insulin Pens, by Type, 2022
  • Figure 4 : European Market Shares of Insulin Pens, by Type, 2022
  • Figure 5 : Asia-Pacific Market Shares of Insulin Pens, by Type, 2022
  • Figure 6 : Rest of the World Market Shares of Insulin Pens, by Type, 2022
  • Figure 7 : Global Market Shares of Insulin Pens, by Onset Time, 2022
  • Figure 8 : Global Market Shares of Long-Acting Insulin Pens, by Region, 2022
  • Figure 9 : Global Market Shares of Intermediate-Acting Insulin Pens, by Region, 2022
  • Figure 10 : Global Market Shares of Short-Acting Insulin Pens, by Region, 2022
  • Figure 11 : Global Market Shares of Rapid-Acting Insulin Pens, by Region, 2022
  • Figure 12 : North American Market Shares for Insulin Pens, by End User, 2022
  • Figure 13 : European Market Shares for Insulin Pens, by End User, 2022
  • Figure 14 : Asia-Pacific Market Shares for Insulin Pens, by End User, 2022
  • Figure 15 : Rest of the World Market Shares for Insulin Pens, by End User, 2022
  • Figure 16 : Global Market Shares of Insulin Pens, by Company, 2022
  • Figure 17 : Global Market Shares of Insulin Pens, by Product, 2022
  • Figure 18 : Global Insulin Market, by Product, Sales Revenue, 2022
  • Figure 19 : AstraZeneca: Revenue Share, by Country, 2022
  • Figure 20 : Merck & Co. Inc.: Annual Revenue, by Segment, 2020-2022
  • Figure 21 : Novartis AG: Innovative Medicine, Market Share, by Region, 2022
  • Figure 22 : Novartis AG: Market Share, by Region, 2022
  • Figure 23 : Sanofi: Annual Revenue, by Region, 2022
  • Figure 24 : Sanofi: Revenue, by Segment, 2022
  • Figure 25 : Viatris Inc.: Sales Share, by Region, 2022
目次
Product Code: MDS102A

This report examines the global insulin pen market. It includes a detailed analysis and prediction of commercially significant products such as reusable and disposable insulin pens. This report investigates global insulin pen market patterns and features between 2022–2028, offering valuable insights and forecasts.

Report Scope:

This report thoroughly examines the worldwide market size of global insulin pen delivery technology, enhancing its appeal to stakeholders and readers alike. Current and historical market revenues are estimated based on the type, duration, end user and region.

Report Includes:

  • An overview of the global market for insulin pen
  • Analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Evaluation of the current market size and revenue growth prospects specific to insulin pen, accompanied by a comprehensive market share analysis categorized by type, onset time, end user, and geographical region
  • A look at the innovations, technological advancements, and the launch of novel products from market players
  • Detailed analysis of the regulatory framework and policies and product pipeline of the industry, and discussion on ESG challenges and ESG practices in the insulin pen market
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Secondary Research
  • Geographic Breakdown
  • Segmentation Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Market Summary
  • Report Highlights

Chapter 3 Market Overview and Definitions

  • Overview
  • Diabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Role of Insulin
  • Diabetes Treatment
  • Market Dynamics
  • Market Drivers
  • Market Restrains
  • Market Opportunities
  • Market Challenges

Chapter 4 Market Breakdown by Region

  • Market Overview and Discussion
  • Market Size and Forecast
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 5 Market Breakdown by Onset Time

  • Market Overview and Discussion
  • Long-Acting Insulin
  • Rapid-Acting Insulin
  • Intermediate-Acting Insulin
  • Short-Acting Insulin
  • Market Size and Forecast
  • Long-Acting Insulin Pens
  • Intermediate-Acting Insulin Pens
  • Short-Acting Insulin Pens
  • Rapid-Acting Insulin Pens

Chapter 6 Market Breakdown by End User

  • Market Overview
  • Hospitals
  • Pharmacies
  • Market Size and Forecast
  • Global Insulin Pen End-Users Market
  • North American End-User Market
  • European End-User Market
  • Asia-Pacific End-User Market
  • Rest of the World End-User Market

Chapter 7 ESG Development

  • Introduction
  • Environmental
  • Social
  • Governance
  • Case Study
  • Novo Nordisk A/S
  • Concluding Remarks from BCC

Chapter 8 Competitive Landscape

  • Overview and Industry Scenario
  • Company Shares
  • Recent Key Developments

Chapter 9 Company Profiles

  • ASTRAZENECA
  • BIOCON
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • ELI LILLY AND CO.
  • JOHNSON & JOHNSON SERVICES INC.
  • MERCK & CO. INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI
  • VIATRIS INC.

Chapter 10 Appendix: Acronyms

  • List of Acronyms